Clinical Trials Logo

Filter by:
NCT ID: NCT03124628 Withdrawn - Cerebral Palsy Clinical Trials

Effects of Flywheel Exercise on Muscle and Walking Function in Teenagers and Young Adults With Cerebral Palsy

CP-Flywheel
Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The main purpose of this project is to improve physical function and muscle health in teenagers and young adults with cerebral palsy (CP) by using an eccentric-overload resistance exercise model Specific aims 1. To compare the efficacy of eccentric-overload vs. weight stack resistance exercise in inducing muscle, functional and gait performance adaptations in teenagers with CP. 2. To increase force, power and muscle mass in the lower limbs of patients with cerebral palsy. 3. To improve gross motor function, balance and gait through eccentric-overload resistance exercise in teenagers suffering from cerebral palsy. We hypothesize that the time-effective flywheel resistance exercise paradigm will result in greater gains in muscle mass and function in teenagers with CP, when compared with conventional weight-stack technology. Importantly, we believe these adaptations will be translated into enhanced gross motor function, balance and gait performance. Forty teenagers and young adults (age range 16-23 yr) with spastic CP will be recruited. They will be randomly assigned to flywheel (FL; n=20) or weight-stack (WS; n=20) resistance exercise. During 8 weeks, all the teenagers will follow a standard resistance exercise training program within the Stockholm Habilitation Center system. In addition, patients will perform either flywheel (FL group) or conventional (WS group) leg press resistance exercise twice per week. Muscle force, power and activity (electromyography; EMG), leg extension lag, co-contraction, balance, functional mobility, gait quality, and muscle and fat thickness of lower extremities are assessed in all patients before and after the 8-week intervention (Fig. 1).

NCT ID: NCT03040453 Withdrawn - Clinical trials for Hepatocellular Carcinoma

Immunological Response After Ablative Therapy in the Liver

IRAL
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Local ablative treatment of Hepatocellular Carcinoma is performed primary on patients not eligible for liver transplant or liver resection. At our Hospital two different methods are used: Microwave ablation, where the tumor cells are heated up and killed, and Irreversible electroporation, where the tumor cells are exposed to an electrical field and nano-pores are formed in the cell membranes and the cells go into apoptosis (programed cell death). Previous studies have shown effects on the immune system after ablative therapies. The purpose of this study is to compare the immunological response after the wo different methods of killing the tumor cells.

NCT ID: NCT02974322 Withdrawn - Crohn Disease Clinical Trials

A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease

Start date: December 1, 2017
Phase: Phase 3
Study type: Interventional

The purpose of study is to test the effect of an experimental medication GED-0301(mongersen) and evaluate its safety in patients (≥ 12 years of age) with active Crohn's disease. The study will test GED-0301 compare to placebo for 12 weeks. The study treatment is blinded which means that patients and the study doctor will not know which treatment has been assigned. Patients in this study will be allowed treatment with stable doses of oral aminosalicylates, oral corticosteroids, immunosupressants and antibiotics for the treatment of Crohn's disease. Adolescent patients will also be allowed treatment with stable doses of exclusive enteral nutrition and growth hormone. All patients who complete the study will have the option to enter a long term active treatment study.

NCT ID: NCT02900183 Withdrawn - Clinical trials for Alpha-1 Antitrypsin Deficiency

Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels

Start date: October 2016
Phase: Phase 2
Study type: Interventional

Patients with Alpha-1 Antitrypsin Deficiency (AATD) will be enrolled to receive multiple doses of ARC-AAT Injection. All subjects will require a pre-dose biopsy and a biopsy post last dose.

NCT ID: NCT02711059 Withdrawn - Diabetes Clinical Trials

Insulin Resistance in Primary Hyperparathyroidism

IRIPH
Start date: October 2015
Phase: N/A
Study type: Interventional

The aims of this study is to analyse if insulin resistance in primary hyperparathyroidism (pHPT) is normalised after parathyroid adenomectomy and if glucose tolerance test may be useful as a diagnostic tool by predicting potential improvement of insulin sensitivity after biochemical cure of pHPT.

NCT ID: NCT02605538 Withdrawn - Cystic Fibrosis Clinical Trials

Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively

Start date: September 1, 2015
Phase: N/A
Study type: Interventional

CF patients are at risk for hepatic disease. Vaccination is recommended to all CF patients according to European consensus. The aim of the study is to vaccinate as many patients as possible and to follow up whether immunization has been complete.

NCT ID: NCT02522247 Withdrawn - Clinical trials for Obstructive Sleep Apnea

RCT Between UPP and Controls in Adult OSA

Start date: n/a
Phase: N/A
Study type: Interventional

To compare the effect of uvulopalatoplasty with no treatment in treating adult OSA.

NCT ID: NCT02475304 Withdrawn - Psoriatic Arthritis Clinical Trials

Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis

Start date: May 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate, whether FP187 is effective in the treatment of mild to moderate psoriatic arthritis.

NCT ID: NCT02458105 Withdrawn - Acute Psychosis Clinical Trials

Acceptance & Commitment Therapy for Psychotic Inpatients

Start date: April 2015
Phase: N/A
Study type: Interventional

The overarching aim of the research project is to investigate whether Acceptance & Commitment Therapy (ACT) is an efficacious psychotherapeutic method of treatment for inpatients suffering from acute psychosis. The method will be applied in two ways. Firstly, as an individual treatment for patients. Secondly, as an integrated part of the daily work on an inpatient ward, administered by nurses and assistant nurses trained in the method.

NCT ID: NCT02415257 Withdrawn - Clinical trials for Vestibular Schwannoma

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Start date: April 2015
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether vestibular and postural compensation following schwannoma surgery is improved by ablating vestibular function prior to surgery, even if vestibular function is absent according to modern assessment techniques